The Steroid Trade-Off: Why Treating Inflammation Can Affect Blood Sugar
Steroids are powerful anti-inflammatory medicines. They can be useful for conditions ranging from asthma and allergic reactions to certain joint and musculoskeletal problems.
But there is an important trade-off that patients may not always hear about: corticosteroids can raise blood glucose levels.
For someone with diabetes or prediabetes, this effect can be particularly relevant. And even people without diagnosed diabetes can experience temporary increases in blood sugar after certain steroid treatments.
Understanding this effect does not mean steroids should be avoided. It means the potential benefits and risks should be considered together.

Why Do Steroids Raise Blood Sugar?
Corticosteroids can affect the way the body handles glucose.
They can cause the liver to release more glucose while also making the body's tissues less sensitive to insulin. As a result, more glucose can remain in the bloodstream.
The effect can vary considerably depending on:
The type of steroid
The dose
How it is administered
How long it is used
A person's underlying metabolic health
Systemic corticosteroid therapy has been associated with an increased risk of hyperglycemia in clinical studies.
Can a Steroid Injection Affect Blood Sugar?
Yes.
A steroid injection given into a joint or surrounding tissue is intended to act locally, but some of the medication can still have systemic effects.
A systematic review found that all seven studies reviewed showed increases in blood glucose after intra-articular steroid injections in people with diabetes. In many cases, the rise occurred within 24–72 hours.
The increase is usually temporary, but the magnitude varies between individuals.
Research has also found differences depending on the injection site and a person's baseline glucose control. For example, one study found significant short-term increases after knee injections, while poorer pre-injection glucose control was associated with greater elevations.
Who Should Pay Particular Attention?
People who may need closer glucose monitoring include those with:
Diabetes
Prediabetes
Previously elevated blood glucose
A history of steroid-related hyperglycemia
Other risk factors for diabetes
This does not mean these patients cannot receive steroid treatment.
Instead, their healthcare professional may consider their glucose control when deciding whether a steroid is appropriate and how closely glucose should be monitored afterward.
What Should Patients Watch For?
After steroid treatment, people with diabetes may notice higher-than-usual glucose readings.
Possible symptoms of significant hyperglycemia include:
Increased thirst
Frequent urination
Fatigue or weakness
Blurred vision
However, blood glucose can rise without causing obvious symptoms. Monitoring is therefore more reliable than waiting to feel different.
If you monitor glucose at home, follow the monitoring instructions provided by your healthcare professional after steroid treatment.
Does This Mean Steroids Should Be Avoided?
Not necessarily.
Steroids can provide meaningful relief from inflammation and are an established treatment for many conditions.
The important question is whether the expected benefit outweighs the potential risks for that particular patient.
A patient with well-controlled diabetes receiving a single injection may have a very different risk profile from someone with poorly controlled diabetes receiving repeated or high-dose steroid treatment.
That is why treatment decisions should be individualized rather than based on a blanket rule.
The Bottom Line
Steroids can be highly effective for controlling inflammation, but their benefits come with potential metabolic effects.
Blood glucose may rise after systemic steroids and can also temporarily increase after some local steroid injections. The effect is particularly important for people with diabetes or other risk factors for hyperglycemia.
If you are considering steroid treatment, tell your healthcare professional if you have diabetes, prediabetes, or a history of elevated blood sugar.
The goal is not simply to control inflammation. It is to choose a treatment approach that considers both the condition being treated and the patient's overall metabolic health.
Trusted References
PubMed / Journal of Bone and Joint Surgery Reviews — Systematic review of blood glucose changes following intra-articular steroid injections.
PubMed / BMJ — Systematic review and meta-analysis of metabolic adverse events associated with systemic corticosteroid therapy.
NHS / MyHealth London — Patient guidance on steroids, diabetes, and steroid-related glucose changes.
University College London Hospitals (UCLH) — Steroid-induced diabetes and mechanisms of steroid-related hyperglycemia.



Comments